DIABETES
AND MACROVASCULAR DISEASE
Lugano
(Switzerland)
April 19-21, 2001
Please
select the abstracts you want to download.
The files are all in Microsoft Word format and for your convenience
they are all compressed to save time in downloading them.
If your PC doesn't have Win Zip you can download it for free simply
by clicking here.
Thursday, April 19, 2001
SESSION
1: SCOPE OF THE PROBLEM AND NEW APPROACHES
Chairs: A. Chait; R. Paoletti
. |
Topic |
Speaker |
16.30-17.00 |
Opening
Remarks |
|
17.00-17.45 |
Use
of PPARalpha Agonists for the Treatment of Insulin
Resistance and Type II Diabetes |
Prof. J.-C. Fruchart (France) |
17.45-18.00 |
Discussion |
. |
18.00-18.45 |
Epidemiology
of CVD in Diabetes |
Prof.
J.H. Fuller (UK) |
18.45-19.00 |
Discussion |
. |
19.00 |
End
of the Session |
. |
19.30 |
Welcome
Reception |
. |
Friday,
April 20, 2001
morning
SESSION
2: PATHOGENESIS OF VASCULAR DISEASE
Chairs: M.-R. Taskinen; G. Noseda
. |
Topic |
Speaker |
9.00-9.45 |
Pathobiology
of Atherosclerosis in Diabetes |
Prof. A. Chait
(USA) |
9.45-10.00 |
Discussion |
.. |
10.00-10.45 |
Endothelial
Dysfunction in Diabetes |
Prof.
H. Yki-Järvinen (Finland) |
10.45-11.00 |
Discussion |
. |
11.00-11.20 |
Coffee
Break |
. |
11.20-12.05 |
Coagulopathies
in Diabetes |
Prof.
I. Juhan-Vague (France) |
12.05-12.20 |
Discussion
|
.. |
12.20 |
End
of the Session |
. |
12.20-13.30 |
Lunch |
. |
afternoon
SESSION
3: RISK FACTORS OF CVD IN DIABETES
Chairs: R. Holman; H. Yki-Järvinen
. |
Topic |
Speaker |
13.30-14.15 |
Relationship
of Hypertension and Renal Disease to Atherosclerosis
in Diabetes |
Prof. H.-H. Parving
(Denmark) |
14.15-14.30 |
Discussion |
.. |
14.30-15.15 |
Lipids
and Lipoproteins as CHD Risk Factors in Diabetes |
Prof.
M.-R. Taskinen
(Finland) |
15.15-15.30 |
Discussion |
. |
15.30-15.50 |
Coffee
Break |
.. |
15.50-16.35 |
CVD
Risk Factors Associated with Intra-abdominal
Obesity and Insulin Resistance |
Prof.
Y. Matsuzawa
(Japan) |
16.35-16.50
16.50-18.20
|
Discussion
WORKSHOP 1:
Evaluation of Risk Factors in the Clinical
Practice
Chairs:
Group 1: J.H. Fuller and M.-R. Taskinen
Group 2: J.D. Brunzell and H.-H. Parving
Group 3: A. Chait and Y. Matsuzawa
Group 4: H. Yki-Järvinen and D.W. Erkelens
|
.. |
18.20 |
End
of the Session |
. |
Saturday,
April 21, 2001
morning
SESSION
4: LESSONS FROM CLINICAL TRIALS
Chairs: D.W. Erkelens; U. Keller
. |
Topic |
Speaker |
9.00-9.45 |
Effect
of Glucose and Glycemic Control |
Prof. R.R. Holman
(UK) |
9.45-10.00 |
Discussion |
.. |
10.00-10.45 |
Multifaceted
Approach to Atherosclerosis Prevention in
Type 1 and 2 Diabetes |
Prof.
J.D. Brunzell
(USA) |
10.45-11.00 |
Discussion |
. |
11.00-11.20 |
Coffee
Break |
. |
11.20-12.05 |
Clinical
Trials: Lipids and Hypertension |
Prof.
M.-R. Taskinen
(Finland)
Prof. H.-H. Parving
(Denmark)
|
12.05-12.20 |
Discussion
|
. |
12.20 |
End
of the Session |
. |
12.20-13.30 |
Lunch |
. |
afternoon
SESSION
5: TREATMENT OF VASCULAR DISEASE IN DIABETES
Chairs: A. Chait; J.-C. Fruchart
. |
Topic |
Speaker |
13.30-14.15 |
Need
for Aggressive Treatment Strategy in Primary
and Secondary Prevention |
Prof.D.W. Erkelens
(The Netherlands) |
14.15-14.30 |
Discussion |
. |
14.30-15.15 |
How
to Treat Acute Coronary Syndromes |
Prof.
L. Rydén
( Sweden) |
15.15-15.30 |
Discussion |
. |
15.30-15.50 |
Coffee
Break |
. |
15.50-16.35 |
Pleiotropic
Effects of Statins in Diabetes and Vascular
Diseases |
Prof.
R. Paoletti
(Italy) |
16.35-16.50
16.50-18.20 |
Discussion
WORKSHOP 2:
How to Achieve Optimal Management of Cardiovascular
Risk Factors
Chairs:
Group 1: A. Chait and I. Juhan-Vague
Group 2: J. Brunzell and U. Keller
Group 3: R. Holman and L. Rydén
Group 4: H. Yki-Järvinen and G. Noseda
|
.. |
18.20 |
End
of the Course |
. |
|
|
|